Verdun, Canada Clinical Trials

A listing of Verdun, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 57 clinical trials
A Study to Evaluate the Safety Pharmacokinetics and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

kras
metastatic malignant solid tumor
kras g12c mutation
solid tumour
ki-ras
Jewish General Hospital; Sir Mortimer B. Davis
 (3.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +7 other locations
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

prostatic neoplasm
testosterone
combined modality therapy
taxane
docetaxel
Centre hospitalier de l'Universit de Montr al (CHUM) Centre de Recherche
 (4.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +21 other locations
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

myozyme
deficiency
replacement therapy
gaa gene
glycogen storage disease type ii
Investigational Site Number 124004
 (3.8 away) Contact site
  • 0 views
  • 22 Dec, 2020
  • +168 other locations
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

muscle rigidity
datscan
genetic testing
modafinil
alpha-synuclein
McGill University
 (3.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +45 other locations
Cell-free DNA in Hereditary And High-Risk Malignancies

The goal of this study is to develop an effective, sensitive blood test that can detect early tumours in patients with known or suspected hereditary cancer syndromes (HCS). If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier cancer detection. …

hereditary cancer syndromes
cancer
blood test
hereditary cancer
cell-free dna
Jewish General Hospital
 (4.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
Pharmacokinetics Pharmacodynamics and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to …

SARS
acute respiratory syndrome (sars)
CHU Sainte-Justine
 (3.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +34 other locations
A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease

This study aims to identify and assess new CMR techniques that can improve current CMR protocols.

MRI
respiratory system
a 10
heart disease
McGill University Health Center
 (1.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location